NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Other Accumulated Expenses (2020 - 2025)

NeuroSense Therapeutics' (NRSN) quarterly Other Accumulated Expenses came in at $1.7 million in Q4 2025, up 106.37% year-over-year from $832000.0 in Q4 2024, and up 54.68% quarter-over-quarter from $1.1 million in Q2 2025.

Analysis

NeuroSense Therapeutics (NRSN) Other Accumulated Expenses (2020 - 2025) Analysis & Trends

NeuroSense Therapeutics has disclosed Other Accumulated Expenses across 6 years of filings, most recently posting $1.7 million for Q4 2025.

  • In Q4 2025, Other Accumulated Expenses rose 106.37% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (up 106.37% YoY), while the FY2025 annual figure was $1.7 million, up 106.37% from the prior year.
  • Other Accumulated Expenses came in at $1.7 million for Q4 2025 at NeuroSense Therapeutics, up from $1.1 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.4 million in Q3 2024 to a low of $558000.0 in Q4 2021.
  • Average Other Accumulated Expenses over 5 years is $1.4 million, with a median of $1.4 million recorded in 2023.
  • Year-over-year, Other Accumulated Expenses soared 758.46% in 2021 and slumped 58.4% in 2024.
  • Over 5 years, Other Accumulated Expenses stood at $558000.0 in 2021, then jumped by 120.07% to $1.2 million in 2022, then surged by 62.87% to $2.0 million in 2023, then plunged by 58.4% to $832000.0 in 2024, then surged by 106.37% to $1.7 million in 2025.
  • Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.7 million in Q4 2025, $1.1 million in Q2 2025, and $832000.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.72 Mn
Jun 30, 2025 1.11 Mn
Dec 31, 2024 832,000.00
Sep 30, 2024 2.39 Mn
Jun 30, 2024 2.03 Mn
Mar 31, 2024 2.15 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2023 1.90 Mn
Jun 30, 2023 1.92 Mn
Mar 31, 2023 1.37 Mn
Dec 31, 2022 1.23 Mn
Sep 30, 2022 605,000.00
Jun 30, 2022 616,000.00
Mar 31, 2022 1.05 Mn
Dec 31, 2021 558,000.00
Dec 31, 2020 65,000.00
API Access

NeuroSense Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NRSN&period=max&api_key=YOUR_API_KEY